Latest News｜Institute for Biotechnology and Medicine Industry│IBMI

Latest News

Date	Subject	Media
2026-01-14	OBI Pharma’s New Drug Granted Orphan Drug Designation in the U.S.	Economic Daily News
2026-01-14	DR.WU SKINCARE Posts Q3 EPS of NT$2.47 as Non-Operating Income Rebounds, Returning to Profitability for the Quarter	Economic Daily News
2026-01-04	Global Pharmaceutical Supply Chain Reshaped: Adimmune Chairman Highlights Industry Resilience and Accelerates International GMP Capacity Expansion	Investor
2026-01-04	TCI Launches Biotech 2.0 Plan with Asset-Light, Distributed Strategy	Commercial Times
2026-01-04	CDIB Capital Group’s Biotech Fund CEO Wu Hsin-Fang: Strategic Alliances Key to Seizing Opportunities	Economic Daily News
2026-01-04	Bora Pharmaceuticals Reports Q3 EPS of NT$5.09; Board Approves Share Buyback	Economic Daily News
2026-01-04	Tanvex BioPharma Narrows Loss in First Three Quarters; Q3 Revenue Hits Record with Boost from Biosimilars Launch	Commercial Times
2026-01-04	Senhwa Biosciences Teams Up with CancerFree Biotech to Leverage Tumor Avatar Platform for New Drug Development	MoneyDJ
2026-01-04	DARWIN PRECISIONS and AUO Partner with Tungs' Taichung Metroharbor Hospital to Launch a New Era of Smart Elderly Rehabilitation	Economic Daily News
2026-01-04	EirGenix Strikes Second Breast Cancer Biosimilar Deal with Sandoz, Total Signing and Milestone Payments Reach US$152 Million	Investor

■ Most Watched

■ Industry Watch

■ IBMI News

Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.

Address：9F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City , Taiwan (R.O.C.) Contact Number：(02)2655-8168 Fax：(02)2655-7978